27.09.2017
- Pharmaceutical companies are experiencing numerous challenges such as increasing cost pressures, declining autonomy or protocol-driven care. The reaction has to go beyond...
21.04.2016
- Non-profit group the Drugs for Neglected Diseases initiative (DNDi) and Egyptian drug maker Pharco Pharmaceuticals have teamed up to launch a low-cost hepatitis C combination...
02.02.2016
- The US Food and Drug Administration (FDA) has granted priority review to US drug maker Merck & Co for bezlotoxumab, an antitoxin for preventing the recurrence of Clostridium...
07.10.2015
- The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...
21.05.2015
- Johnson & Johnson's Janssen Pharmaceuticals offshoot has told analysts it plans to seek regulatory approval for more than 10 new drugs up to 2019, each with the potential to...
06.02.2015
- US regulators intend to rescind the "breakthrough therapy" designation for Merck & Co's hepatitis C combination treatment, a decision that could delay approval of the product by...
20.01.2015
- Europe, where about 15 million people are believed to be infected with hepatitis C, could become the next battleground between US drugmakers Gilead Sciences and AbbVie in their...
02.10.2014
- France plans to implement a tax on hepatitis C drugs in an effort to lower the high prices that the government of prime minister Francois Hollande believes threaten the country's...
